Vishal is a Director of Corporate Business Development and Strategy at H. Lundbeck A/S where he focuses on searching and evaluating pre-clinical, clinical and digital opportunities for partnering. Over the last 10+ years, Vishal led teams at several stages of the drug discovery, development and commercialization value chain at Eisai, GSK and MSD, working across Europe, the United States and Asia to support the development of small molecule-, biologics- and gene therapy-medicines.

Vishal holds a PhD in Developmental Neurobiology from University College London, a Master’s degree in Experimental Neuroscience from Imperial College London and a Bachelor’s degree in Biomedical Science from King’s College London.